Many new names sounded as if they’d been cooked up by a medieval monk. HIV-1 would henceforth be known as Lentivirus ...

The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...

A German research team’s discoveries about autoimmune diseases are opening up new possibilities for patients with lupus and ...

The White House gives agencies more leeway with one of the few tools against meth use: financial incentives, or "contingency ...

Jimmy Carter’s example — as a leader, a humanitarian, and a human — can guide us through these unclear times, writes WHO ...

In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...

Transcarent raised $126 million in 2024, and the cash acquisition is being funded by General Catalyst and Tullman’s 62 ...

Scribe Therapeutics, co-founded by Jennifer Doudna, is reducing staff, the latest layoffs among companies focused on CRISPR ...

Health insurers like UnitedHealth are under tremendous public scrutiny for tactics such as prior authorization and care ...

A new study found that high-frequency stimulation reduced spasticity, and improved patients' ability to walk after spinal ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The beleaguered Belgian firm Galapagos is splitting itself into two companies, with the brandname biotech prioritizing ...